OMACETAXINE MEPESUCCINATE
| Brand name | SYNRIBO |
|---|---|
| Active ingredient | OMACETAXINE MEPESUCCINATE |
| Strength | 3.5MG/VIAL |
| Dosage form | POWDER |
| Route | SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | October 2012 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 6987103 | October 2026 | use U-1300 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.